Skip to main content
Premium Trial:

Request an Annual Quote

Halo Precision Diagnostics: John Craighead

Halo Precision Diagnostics has appointed John Craighead its chief operating officer and CFO. He has more than two decades of experience in the life sciences and financial services sectors and recently was CFO and head of corporate development at biopharmaceutical firm Elpiscience. Before that, Craighead was VP of strategy, corporate development, and investor relations at Grail, and he has held leadership posts at Sanofi, Atara Biotherapeutics, Lehman Brothers, and Human Genome Sciences. Menlo Park, California-based Halo Precision Diagnostics leverages advanced imaging and molecular diagnostic technologies for early disease detection. Disease areas of interest include prostate cancer, breast cancer, and cardiovascular and neurodegenerative diseases.